Published April 2011 | Version v1
Journal article Metadata-only

Present and future of FDG-PET/CT in ovarian cancer

Creators

  • 1. Inst. of Biomedical Research and Innovation, Kobe, Hyogo (Japan)
  • 2. Keio Univ., School of Medicine, Tokyo (Japan)
  • 3. Dokkyo Medical Univ., Hospital, Mibu, Tochigi (Japan)
  • 4. Dokkyo Univ., School of Medicine, Mibu, Tochigi (Japan)
  • 5. Kobe Univ., Graduate School of Medicine, Kobe, Hyogo (Japan)

Description

Integrated Fluorodeoxyglucose-positron emission tomograph (FDG-PET)/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients. (author)

Additional details

Publishing Information

Journal Title
Annals of Nuclear Medicine
Journal Volume
25
Journal Issue
3
Journal Page Range
p. 155-164
ISSN
0914-7187

INIS

Country of Publication
Japan
Country of Input or Organization
Japan
INIS RN
42098765
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ACCURACY; CARCINOMAS; CAT SCANNING; CONTRAST MEDIA; FLUORODEOXYGLUCOSE; LYMPH NODES; METASTASES; OVARIES; PATIENTS; POSITRON COMPUTED TOMOGRAPHY; REVIEWS; SENSITIVITY; SPECIFICITY
Descriptors DEC
ANTIMETABOLITES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DOCUMENT TYPES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FEMALE GENITALS; GONADS; LYMPHATIC SYSTEM; NEOPLASMS; ORGANS; TOMOGRAPHY